Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
12.91
+0.28 (2.22%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Bioventus Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 581.85 | 568.09 | 573.28 | 512.35 | 512.12 | 430.9 |
Revenue Growth | 3.14% | -0.91% | 11.89% | 0.04% | 18.85% | 34.17% |
Gross Profit Gross Profit Growth | 399.45 | 388.16 | 388.23 | 328.19 | 331.08 | 302.71 |
Operating Income Operating Income Growth | 60.61 | 56.34 | 36.63 | 2.03 | -34.66 | 21.05 |
Net Income Net Income Growth | 54.46 | 22.73 | -36.13 | -156.23 | -158.7 | -6.6 |
Earnings Per Share EPS Growth | 0.78 | 0.33 | -0.56 | -2.49 | -2.59 | -0.15 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
U.S. U.S. Growth | 513.71 | 502.1 | 506.81 | 449.86 | 455.25 | 387.55 |
International International Growth | 68.14 | 65.99 | 66.47 | 62.49 | 56.87 | 43.35 |
Total Total Growth | 581.85 | 568.09 | 573.28 | 512.35 | 512.12 | 430.9 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 30.39 | 51.24 | 41.58 | 36.96 | 30.19 | 43.93 |
Total Debt Total Debt Growth | 263.75 | 311.35 | 356.06 | 420.62 | 436.1 | 376.22 |
Net Cash (Debt) Net Cash Growth | -233.36 | -260.11 | -314.47 | -383.66 | -405.92 | -332.29 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.35 | -3.77 | -4.87 | -6.12 | -6.61 | -7.31 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 96.87 | 74.67 | 38.8 | 15.34 | -13.54 | 22.99 |
Capital Expenditures CapEx Growth | -2.59 | -2.56 | -1.01 | -7.36 | -11.52 | -13.52 |
Free Cash Flow Free Cash Flow Growth | 94.29 | 72.11 | 37.79 | 7.98 | -25.06 | 9.47 |
Free Cash Flow Growth | 176.51% | 90.83% | 373.43% | - | - | -82.85% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 68.65% | 68.33% | 67.72% | 64.06% | 64.65% | 70.25% |
Operating Margin | 10.42% | 9.92% | 6.39% | 0.40% | -6.77% | 4.88% |
Pretax Margin | 6.64% | 4.53% | -9.13% | -23.64% | -36.91% | 2.20% |
Profit Margin | 9.36% | 4.00% | -6.30% | -30.49% | -30.99% | -1.53% |
FCF Margin | 16.20% | 12.69% | 6.59% | 1.56% | -4.89% | 2.20% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.51 | 21.92 | - | - | - | - |
Forward PE | 16.19 | 9.79 | 20.00 | 21.82 | 17.17 | 21.50 |
P/FCF Ratio | 11.51 | 6.91 | 18.16 | 41.57 | - | 90.94 |
PS Ratio | 1.87 | 0.88 | 1.20 | 0.65 | 0.32 | 2.00 |